Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
ICE-T is a multimodal, opioid-sparing postoperative pain management regimen developed by researchers at University Hospitals Cleveland Medical Center. The acronym stands for **I**ce packs, **T**oradol (ketorolac), and **T**ylenol (acetaminophen). The regimen consists of the around-the-clock application of local cryotherapy (ice packs) combined with scheduled oral acetaminophen and intravenous ketorolac. It is specifically designed to reduce inpatient narcotic consumption and improve pain control in patients undergoing surgical procedures, such as vaginal pelvic reconstructive surgery and total laparoscopic hysterectomy. Clinical trials have demonstrated that the ICE-T regimen significantly improves pain scores and reduces the need for breakthrough opioids compared to standard postoperative protocols.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Ice T.